MedTrace Logo

Anterior Gen Plus Study

NCT04629807 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-04-04

No results posted yet for this study

Summary

A clinical study evaluating patients treated with the Demineralized Bone Matrix (DBM) as compared to a Cellular Bone Matrix (CBM) in anterior lumbar interbody fusion.

Conditions

  • Spine Fusion

Interventions

PROCEDURE

Anterior Lumbar Interbody Fusion (ALIF)

Intra-Operative Anterior Lumbar Interbody Fusion (ALIF)

Sponsors & Collaborators

  • SeaSpine, Inc.

    lead INDUSTRY

Principal Investigators

  • Muwaffak Abdulhak, MD · Henry Ford Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2022-12-16
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04629807 on ClinicalTrials.gov